Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
| (1R,2S,5R,8S,9R,17R,18R,21S,24R,26S,27S)-5-Hydroxy-2,9,26-trimethyl-3,19,23,28-tetraoxaoctacyclo[16.9.1.118,27.01,5.02,24.08,17.09,14.021,26]nonacosa-11,14-diene-4,10,22,29-tetrone | IC50 | 37500.0 [1] | |
| 5,6-Epxoyphysalin B | IC50 | 27100.0 [1] | |
| Physalin A | IC50 | 50000.0 [1] | |
| Withanolide E | IC50 | 18000.0 [1] | |
| (2R)-2-[(1S)-1-[(8R,9S,10R,13S,14R,17S)-14,17-Dihydroxy-10,13-dimethyl-1-oxo-4,7,8,9,11,12,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-1-hydroxyethyl]-4,5-dimethyl-2,3-dihydropyran-6-one | IC50 | 50000.0 [1] | |
MLA | "Quest Database™ NF-kappaB inhibitor alpha Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 2 Jan. 2026, https://www.aatbio.com/data-sets/nf-kappab-inhibitor-alpha-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2026, January 2). Quest Database™ NF-kappaB inhibitor alpha Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/nf-kappab-inhibitor-alpha-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |